Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Neoantigen Targeted Therapies Market Report 2024

Neoantigen Targeted Therapies Global Market Report 2024 – By Type (Monotherapy, Combination Therapy), By Immunotherapy Type (DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies), By Target Disease Indication (Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer), By Route of Administration (Intradermal, Intravenous, Subcutaneous), By Application (Medical Research Institution, Hospital, and Clinic, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Neoantigen Targeted Therapies Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Neoantigen Targeted Therapies Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Neoantigen Targeted Therapies Market Definition

Neoantigen targeted therapies are a type of precision medicine that concentrates on neoantigens in cancer cells. Neoantigens are distinct antigens that are derived from genetic abnormalities or modifications present in cancer cells. It is used to harness the body's immune system to recognize and attack cancer cells specifically by targeting these neoantigens.

The main types of neoantigens targeted therapies are monotherapy and combination therapy. The term monotherapy refers to a medical approach to treating a problem or disease that uses only one medicine or therapy. The various immunotherapy types include DNA or RNA-based vaccines, protein-based vaccines, dendritic cell vaccines, and TIL-based therapies that target various disease indications such as colorectal cancer, renal cell carcinoma, non-small cell lung cancer, bone cancer, and gynecological cancer. The various routes of administration include intradermal, intravenous, and subcutaneous, and the various applications include medical research institutions, hospitals, clinics, and others.

Neoantigen Targeted Therapies Market Segmentation

The neoantigen targeted therapies market covered in this report is segmented –

1) By Type: Monotherapy, Combination Therapy

2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies

3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer

4) By Route of Administration: Intradermal, Intravenous, Subcutaneous

5) By Application: Medical Research Institution, Hospital, and Clinic, Other Applications

Global Neoantigen Targeted Therapies Market Size 2023 to 2028: Graph

Neoantigen Targeted Therapies Market Size 2024 And Growth Rate

The neoantigen targeted therapies market size has grown exponentially in recent years. It will grow from $2.43 billion in 2023 to $3.39 billion in 2024 at a compound annual growth rate (CAGR) of 39.3%. The growth in the historic period can be attributed to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, clinical success of checkpoint inhibitors, molecular profiling advancements.

Neoantigen Targeted Therapies Market Growth Forecast

The neoantigen targeted therapies market size is expected to see exponential growth in the next few years. It will grow to $11.69 billion in 2028 at a compound annual growth rate (CAGR) of 36.3%. The growth in the forecast period can be attributed to advancements in bioinformatics, precision medicine expansion, neoantigen vaccine development, therapeutic combination strategies, biomarker validation. Major trends in the forecast period include neoantigen resistance management, neoantigen-primed adoptive cell therapies, neoantigen-based combinatorial therapies, integration of real-world data, enhanced predictive models.

Book your 30 minutes free consultation with our research experts

Contact Us

Neoantigen Targeted Therapies Market Driver: Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therapies Market

The increasing incidence of cancer cases is expected to propel the growth of the neoantigen targeted therapies market going forward. The incidence of cancer refers to the number of new cases of cancer in a specific population for a given period. Neoantigen targeted therapies are often used in combination to treat different types of cancer. For instance, the American Cancer Society (ACS), a US-based voluntary health organization, in 2022, the United States had 1.9 million new cancer cases, representing a significant increase compared to previous years. Furthermore, in 2022, in the US, approximately 609,360 deaths were attributed to cancer, emphasizing the profound severity and impact of this disease on individuals and their families. Therefore, the increasing incidence of cancer cases is driving the growth of the neoantigen targeted therapies market.

Neoantigen Targeted Therapies Market Driver: Surge Of Precision Oncology Propels Growth In The Neoantigen Targeted Therapies Market

The rising precision oncology is expected to propel the growth of the neoantigen targeted therapies market going forward. Precision oncology is an approach to cancer treatment that utilizes detailed genetic and molecular information about a patient's tumor to guide the selection of targeted therapies. Precision oncology uses neoantigen-targeted therapies by leveraging advanced genomic analysis to identify unique neoantigens expressed by an individual's cancer cells. The utilization of neoantigen-targeted therapies in precision oncology reflects a strategy to address the specific genetic makeup of each patient's tumor, offering a more personalized and effective treatment option. For instance, in 2021, as per the precision oncology annual trend report by Novartis AG, a Switzerland-based pharmaceutical company, 60% of oncologists frequently use next-generation sequencing (NGS) in over 75% of cases, which indicates a growing percentage of cancer patients benefiting from precision oncology. Therefore, rising precision oncology is driving the growth of the neoantigen targeted therapies market.

Global Neoantigen Targeted Therapies Market Major Players

Major companies operating in the neoantigen targeted therapies market report are F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Company, Kite Pharma Inc., Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Precision Biologics Inc., Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc.

Global Neoantigen Targeted Therapies Market Trend: Biontech Takes Strides In Neoantigen Targeted Therapies With The Launch Of Bnt122 For Colorectal Cancer

Product innovation has emerged as a key trend gaining popularity in the neoantigen targeted therapies market. Major players are focusing on creating innovative products to lead the market. For instance, in October 2021, BioNTech, a Germany-based biotechnology company, expanded its clinical oncology portfolio with the initiation of a Phase 2 clinical trial for ‘BNT122’, a mRNA-based individualized immunotherapy. This trial specifically focuses on colorectal cancer patients. The trial marks an important milestone, as the first patient has been dosed with BNT122. It is designed to harness the power of the immune system by stimulating a targeted T-cell response against neoantigens found in each patient's tumor. The ongoing clinical trial represents an important step forward in BioNTech's mission to develop cutting-edge immunotherapies and expand the treatment options available to cancer patients.

Global Neoantigen Targeted Therapies Market Trend: Strategic Collaboration In Neoantigen Targeted Therapies

Major companies operating in the neoantigen targeted therapies market are adopting a strategic partnership approach to personalize neoantigen vaccines and monoclonal antibody drugs to overcome the challenges of existing immunotherapy in the treatment of solid tumors. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in October 2021, Innovent Biologics, a China-based biopharmaceutical company, partnered with NeoCura Bio-Medical Technology Co. Ltd., a China-based precision healthcare and medical technology company. With this partnership, they aim to evaluate the combination therapy of sintilimab and the neoantigen vaccine NEO_PLIN2101 for cancer treatment in China. This collaboration aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy using sintilimab and NEO_PLIN2101 in cancer patients.

Neoantigen Targeted Therapies Market Merger And Acquisition: Biontech Acquires Kite Pharma's Neoantigen Tcr Cell Therapy Platform

In August 2021, BioNTech SE, a Germany-based biotechnology company, acquired Kite Pharma's Neoantigen TCR cell therapy platform for an undisclosed amount. This acquisition aligns with BioNTech's commitment to harnessing the power of the immune system to combat cancer and represents a significant step in the company's ongoing efforts to expand and strengthen its position in the field of innovative cell-based therapies. Kite Pharma is a US-based company focused on cell therapy and immunotherapy that operates in the neoantigen targeted therapy market.

Regional Outlook For The Global Neoantigen Targeted Therapies Market

North America was the largest region in the neoantigen targeted therapies market in 2023. The regions covered in the neoantigen targeted therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neoantigen targeted therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neoantigen targeted therapies market consists of revenues earned by entities by providing services such as the identification and characterization of neoantigens in individual patients, the selection and administration of the appropriate therapy, and the monitoring of patients' responses. The market value includes the value of related goods sold by the service provider or included within the service offering. Neoantigen targeted therapies also include the sale of neoantigen-based cancer vaccines and genetically modified T cells. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The neoantigen targeted therapies market research report is one of a series of new reports from The Business Research Company that provides neoantigen targeted therapies market statistics, including the neoantigen targeted therapies industry global market size, regional shares, competitors with a neoantigen targeted therapies market share, detailed neoantigen targeted therapies market segments, market trends, and opportunities, and any further data you may need to thrive in the neoantigen targeted therapies industry. This neoantigen targeted therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Neoantigen Targeted Therapies Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $3.39 billion
Revenue Forecast In 2033 $11.69 billion
Growth Rate CAGR of 36.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Monotherapy, Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
4) By Route of Administration: Intradermal, Intravenous, Subcutaneous
5) By Application: Medical Research Institution, Hospital, and Clinic, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company; Kite Pharma Inc.; Gilead Sciences Inc.; Amgen Inc.; Moderna Inc.; BioNTech SE; Bavarian Nordic Inc.; Advaxis Inc.; Immatics NV; Precision Biologics Inc.; Iovance Biotherapeutics Inc.; Agenus Inc.; Achilles Therapeutics Plc; Medigene AG; Gritstone Bio Inc.; SQZ Biotechnologies Company; Aduro BioTech Inc.; Inovio Pharmaceuticals Inc.; Gradalis Inc.; EpiVax Inc.; ISA Pharmaceuticals BV; Vaxon Biotech SA; Ziopharm Oncology; Genocea Biosciences Inc.; Cellular Biomedicine Group Inc.; Immunovaccine Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Neoantigen Targeted Therapies Market Characteristics

    3. Neoantigen Targeted Therapies Market Trends And Strategies

    4. Neoantigen Targeted Therapies Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Neoantigen Targeted Therapies Market Size and Growth

    5.1. Global Neoantigen Targeted Therapies Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Neoantigen Targeted Therapies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Neoantigen Targeted Therapies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Neoantigen Targeted Therapies Market Segmentation

    6.1. Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Monotherapy

    Combination Therapy

    6.2. Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    DNA Or RNA-Based Vaccines

    Protein-Based Vaccines

    Dendritic Cell Vaccines

    TIL-Based Therapies

    6.3. Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Colorectal Cancer

    Renal Cell Carcinoma

    Non-Small Cell Lung Cancer

    Bone Cancer

    Gynecological Cancer

    6.4. Global Neoantigen Targeted Therapies Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Intradermal

    Intravenous

    Subcutaneous

    6.5. Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Medical Research Institution

    Hospital And Clinic

    Other Applications

    7. Neoantigen Targeted Therapies Market Regional And Country Analysis

    7.1. Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Neoantigen Targeted Therapies Market

    8.1. Asia-Pacific Neoantigen Targeted Therapies Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Neoantigen Targeted Therapies Market

    9.1. China Neoantigen Targeted Therapies Market Overview

    9.2. China Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Neoantigen Targeted Therapies Market

    10.1. India Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Neoantigen Targeted Therapies Market

    11.1. Japan Neoantigen Targeted Therapies Market Overview

    11.2. Japan Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Neoantigen Targeted Therapies Market

    12.1. Australia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Neoantigen Targeted Therapies Market

    13.1. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Neoantigen Targeted Therapies Market

    14.1. South Korea Neoantigen Targeted Therapies Market Overview

    14.2. South Korea Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Neoantigen Targeted Therapies Market

    15.1. Western Europe Neoantigen Targeted Therapies Market Overview

    15.2. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Neoantigen Targeted Therapies Market

    16.1. UK Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Neoantigen Targeted Therapies Market

    17.1. Germany Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Neoantigen Targeted Therapies Market

    18.5. France Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Neoantigen Targeted Therapies Market

    19.9. Italy Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Neoantigen Targeted Therapies Market

    20.13. Spain Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Neoantigen Targeted Therapies Market

    21.1. Eastern Europe Neoantigen Targeted Therapies Market Overview

    21.2. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Neoantigen Targeted Therapies Market

    22.1. Russia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Neoantigen Targeted Therapies Market

    23.1. North America Neoantigen Targeted Therapies Market Overview

    23.2. North America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Neoantigen Targeted Therapies Market

    24.1. USA Neoantigen Targeted Therapies Market Overview

    24.2. USA Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Neoantigen Targeted Therapies Market

    25.1. Canada Neoantigen Targeted Therapies Market Overview

    25.2. Canada Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Neoantigen Targeted Therapies Market

    26.1. South America Neoantigen Targeted Therapies Market Overview

    26.2. South America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Neoantigen Targeted Therapies Market

    27.1. Brazil Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Neoantigen Targeted Therapies Market

    28.1. Middle East Neoantigen Targeted Therapies Market Overview

    28.2. Middle East Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Neoantigen Targeted Therapies Market

    29.1. Africa Neoantigen Targeted Therapies Market Overview

    29.2. Africa Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Neoantigen Targeted Therapies Market Competitive Landscape And Company Profiles

    30.1. Neoantigen Targeted Therapies Market Competitive Landscape

    30.2. Neoantigen Targeted Therapies Market Company Profiles

    30.2.1. F. Hoffmann-La Roche AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck and Co. Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bristol Myers Squibb Company

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. GlaxoSmithKline plc

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Eli Lilly and Company

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Neoantigen Targeted Therapies Market Other Major And Innovative Companies

    31.1. Kite Pharma Inc.

    31.2. Gilead Sciences Inc.

    31.3. Amgen Inc.

    31.4. Moderna Inc.

    31.5. BioNTech SE

    31.6. Bavarian Nordic Inc.

    31.7. Advaxis Inc.

    31.8. Immatics NV

    31.9. Precision Biologics Inc.

    31.10. Iovance Biotherapeutics Inc.

    31.11. Agenus Inc.

    31.12. Achilles Therapeutics Plc

    31.13. Medigene AG

    31.14. Gritstone Bio Inc.

    31.15. SQZ Biotechnologies Company

    32. Global Neoantigen Targeted Therapies Market Competitive Benchmarking

    33. Global Neoantigen Targeted Therapies Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market

    35. Neoantigen Targeted Therapies Market Future Outlook and Potential Analysis

    35.1 Neoantigen Targeted Therapies Market In 2028 - Countries Offering Most New Opportunities

    35.2 Neoantigen Targeted Therapies Market In 2028 - Segments Offering Most New Opportunities

    35.3 Neoantigen Targeted Therapies Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Neoantigen Targeted Therapies Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: F. Hoffmann-La Roche AG Financial Performance
  • Table 77: Merck and Co. Inc. Financial Performance
  • Table 78: Bristol Myers Squibb Company Financial Performance
  • Table 79: GlaxoSmithKline plc Financial Performance
  • Table 80: Eli Lilly and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Neoantigen Targeted Therapies Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: F. Hoffmann-La Roche AG Financial Performance
  • Figure 77: Merck and Co. Inc. Financial Performance
  • Figure 78: Bristol Myers Squibb Company Financial Performance
  • Figure 79: GlaxoSmithKline plc Financial Performance
  • Figure 80: Eli Lilly and Company Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

Read More

What Is The Healthcare IT Consulting Market Overview In 2022?

Read More

How Will The Stem Cell Assay Market Grow In 2022?

Read More

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Read More

Blood Cancer Drugs Global Market Report 2024 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Rituximab Biosimilars Global Market Report 2024 – By Route Of Administration (Subcutaneous, Intravenous, Molecular Type), By Application (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Mail Order) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acute Myeloid Leukemia Global Market Report 2024 – By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By End-User (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer), By End-User (Hospital, Reference Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

CAR-T Therapy Global Market Report 2024 – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, BCMA, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the neoantigen targeted therapies market?

Neoantigen targeted therapies are a type of precision medicine that concentrates on neoantigens in cancer cells. Neoantigens are distinct antigens that are derived from genetic abnormalities or modifications present in cancer cells. It is used to harness the body's immune system to recognize and attack cancer cells specifically by targeting these neoantigens. For further insights on the neoantigen targeted therapies market, request a sample here

How will the neoantigen targeted therapies market drivers and restraints affect the neoantigen targeted therapies market dynamics? What forces will shape the neoantigen targeted therapies industry going forward?

The neoantigen targeted therapies market major growth driver - Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therapies Market. For further insights on the neoantigen targeted therapies market, request a sample here

What is the forecast market size or the forecast market value of the neoantigen targeted therapies market?

The neoantigen targeted therapies market size has grown exponentially in recent years. It will grow from $2.43 billion in 2023 to $3.39 billion in 2024 at a compound annual growth rate (CAGR) of 39.3%. The growth in the historic period can be attributed to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, clinical success of checkpoint inhibitors, molecular profiling advancements. The neoantigen targeted therapies market size is expected to see exponential growth in the next few years. It will grow to $11.69 billion in 2028 at a compound annual growth rate (CAGR) of 36.3%. The growth in the forecast period can be attributed to advancements in bioinformatics, precision medicine expansion, neoantigen vaccine development, therapeutic combination strategies, biomarker validation. Major trends in the forecast period include neoantigen resistance management, neoantigen-primed adoptive cell therapies, neoantigen-based combinatorial therapies, integration of real-world data, enhanced predictive models. For further insights on the neoantigen targeted therapies market, request a sample here

How is the neoantigen targeted therapies market segmented?

The neoantigen targeted therapies market is segmented
1) By Type: Monotherapy, Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
4) By Route of Administration: Intradermal, Intravenous, Subcutaneous
5) By Application: Medical Research Institution, Hospital, and Clinic, Other ApplicationsFor further insights on the neoantigen targeted therapies market, request a sample here

Which region has the largest share of the neoantigen targeted therapies market? What are the other regions covered in the report?

North America was the largest region in the neoantigen targeted therapies market in 2023. The regions covered in the neoantigen targeted therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the neoantigen targeted therapies market, request a sample here.

Who are the major players in the neoantigen targeted therapies market?

Major companies operating in the neoantigen targeted therapies market report are F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Company, Kite Pharma Inc., Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Precision Biologics Inc., Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc. For further insights on the neoantigen targeted therapies market, request a sample here.

What are the key trends in the neoantigen targeted therapies market?

Major trend in the neoantigen targeted therapies market - Biontech Takes Strides In Neoantigen Targeted Therapies With The Launch Of Bnt122 For Colorectal Cancer. For further insights on the neoantigen targeted therapies market, request a sample here.

What are the major opportunities in the neoantigen targeted therapies market? What are the strategies for the neoantigen targeted therapies market?

For detailed insights on the major opportunities and strategies in the neoantigen targeted therapies market, request a sample here.

How does the neoantigen targeted therapies market relate to the overall economy and other similar markets?

For detailed insights on neoantigen targeted therapies market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the neoantigen targeted therapies industry?

For detailed insights on the mergers and acquisitions in the neoantigen targeted therapies industry, request a sample here.

What are the key dynamics influencing the neoantigen targeted therapies market growth? SWOT analysis of the neoantigen targeted therapies market.

For detailed insights on the key dynamics influencing the neoantigen targeted therapies market growth and SWOT analysis of the neoantigen targeted therapies industry, request a sample here.